The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> February 16, 2015

Interview with the President & CEO: Osprey Medical Inc. (ASX:OSP)

Mike McCormick
Mike McCormick was appointed President & CEO of Osprey Medical Inc. in March 2010. Mr. McCormick has more than 25 years of experience in the medical device industry, and president-level experience with public and private medical device companies. From 2003 to 2008, Mr. McCormick was President and CEO of Anulex Technologies, Inc., a private company focused on developing proprietary technologies to support the healing of spinal soft tissues. Prior to this, he was President of Centerpulse Spine-Tech, a publicly traded full-line supplier of innovative spinal technologies with over 400 employees and $125 million in annual revenues. Mr. McCormick was involved in the successful sale of Centerpulse Inc. to Zimmer in 2003 for $3.2 billion. Early in his career, Mr. McCormick worked at Boston Scientific Scimed for 10 years and Baxter Health Care, where he served in a variety of sales and sales management roles. He received his Bachelor of Business Administration, Business Management from the University of Texas at Austin. Mr. McCormick is Chairman of the board at OrthoCor Medical, Inc., a commercial-stage private company based in Minnesota, and he is a member of the board of directors of Formae, Inc. a private company in the orthopaedics space. Profile
TWST: Could provide a brief overview of the company?

Mr. McCormick: Osprey Medical is focused on technologies that reduce patients' risk when undergoing a cardiovascular procedure that

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy